Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 8
2017 16
2018 12
2019 10
2020 9
2021 5
2022 13
2023 6
2024 9
2025 13
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 26107752

96 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence, Predictors, and Moderators of Relapse in Severe Mental Disorders: Evidence from Ndera Neuropsychiatric Teaching Hospital, Rwanda.
Nkubili C, Uwamungu P, Ntirenganya S, Twizeyimana EF, Kagabo E, Ntakiyisumba E, Musabyimana JC, Nshimiyimana M, Mbabazi A, Niyonsaba E, Uwamwezi B, Baho FU, Sebera F, Nyirandamutsa F, Niyonsenga J. Nkubili C, et al. Rwanda J Med Health Sci. 2025 Nov 27;8(3):631-649. doi: 10.4314/rjmhs.v8i3.15. eCollection 2025 Nov. Rwanda J Med Health Sci. 2025. PMID: 41694278 Free PMC article.
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial.
Mortazavi M, Aminifarsani Z, Rossum IW, Kahn RS, Fleischhacker WW, Davidson M, Weiser M, Siskind D, Leucht S; EULAST Study Group; Hasan A, Wagner E. Mortazavi M, et al. CNS Drugs. 2026 Jan;40(1):99-109. doi: 10.1007/s40263-025-01225-0. Epub 2025 Sep 11. CNS Drugs. 2026. PMID: 40932600 Free PMC article. Clinical Trial.
Safety Outcomes with the Long-Acting Subcutaneous Antipsychotic TV-46000 in Schizophrenia: A Post Hoc Analysis of Behavioral, Neuromotor, Endocrine, and Cardiometabolic Outcomes from Two Phase 3 Studies.
Correll CU, Knebel H, Harary E, Eshet R, Tohami O, Suett M, Sharon N, Franzenburg KR, Kane JM. Correll CU, et al. CNS Drugs. 2025 Nov;39(11):1139-1156. doi: 10.1007/s40263-025-01197-1. Epub 2025 Jul 29. CNS Drugs. 2025. PMID: 40730715 Free PMC article. Clinical Trial.
96 results